Skip to content

S. 1097 · 119th Congress (2025–2027)

Interagency Patent Coordination and Improvement Act of 2025

This bill establishes the Interagency Task Force on Patents to support coordination and communication between the U.S. Patent and Trademark Office (USPTO) and the Food and Drug Administration (FDA) on activities relating to patents for human drugs and biological products.

The task force's duties shall include sharing information about (1) the processes of each agency, including how each agency evaluates applications (e.g., patent applications at the USPTO and new drug applications at the FDA); and (2) new approvals of patents, human drugs, biological products, and new technologies. The task force must also establish a process that requires (1) the USPTO to request from the FDA information relating to certain patent applications to help patent examiners carry out their duties, (2) the FDA to provide such information to the USPTO, and (3) the USPTO to assist the FDA in its ministerial role of listing patents.

Show official title

A bill to amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes.

Reported

This bill’s path

This is S. 1097’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed Senate

  3. Passed House

  4. Sent to President

  5. Signed into law

Sponsor
Sen. Richard J. Durbin (D-IL)
Cosponsors
4 cosponsors

4 original · 0 later

  1. Sen. Christopher A. Coons (D-DE)· Original · Mar 24, 2025
  2. Sen. Chuck Grassley (R-IA)· Original · Mar 24, 2025
  3. Sen. Thom Tillis (R-NC)· Original · Mar 24, 2025
  4. Sen. Peter Welch (D-VT)· Original · Mar 24, 2025
Policy area
Commerce
Subjects
  • Drug safety, medical device, and laboratory regulation
  • Food and Drug Administration (FDA)
  • Intellectual property
  • Intergovernmental relations

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in Senate

    Document: Introduced in Senate

    Sources
  2. Latest
    ▸ 3 committee actions · Mar 24, 2025 – Apr 10, 2025
    1. Referred to committee

      Congressional Record S1804–S1805

      Read twice and referred to the Committee on the Judiciary.

      Sources
    2. Ordered reported

      Committee on the Judiciary. Ordered to be reported with amendments favorably.

      Sources
    3. Reported by committee

      Committee on the Judiciary. Reported by Senator Grassley with amendments. Without written report.

      Sources

Committees

  1. SenateJudiciaryReferred Mar 24, 2025 · Markup Apr 3, 2025 · Reported Apr 10, 2025
    1. Apr 3, 2025 · Meeting

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in Senate
Reported to Senate
Titles (2)
  1. Interagency Patent Coordination and Improvement Act of 2025

    Short title, Display title · Reported to Senate, Introduced in Senate

  2. A bill to amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes.

    Official title · Introduced in Senate